Thailand informed today of promising results in an MRNA vaccine trial for COVID-19 on monkeys, carried out by the National Primate Research Center of Thailand.
Tests with monkeys were highly effective, creating antibodies to prevent coronavirus transmissions without any adverse side effects. Two weeks since the second injection on the 22nd of June, researchers have now taken the monkeys’ blood samples and located a neutralizing antibody in every sample, described as an excitingly positive finding. The next phase is human trials which can begin this October.
The research center will be on the lookout for volunteers for the human trial between August and September and will inject the first doses in October.
The human trial will be carried out in three phases and if it shows promising results, mass manufacturing of the vaccine and vaccination registration will be undertaken. The authority may even trade aspects of its technology with foreign nations.
Was this article helpful?
Thailand’s fastest-growing web collective dedicated to sharing our love of Thailand and neighboring South-East Asia.